Combo immunotherapy may herald new standard of care for kidney cancer
Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from 20…
Browsing: ipilimumab-nivolumab
Study provides path for new immunotherapy approaches to prostate cancer
Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways…